{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-26-000040","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-08-06T20:11:02+00:00","discovered_at":"2026-08-06T20:12:01.655740+00:00","generated_at":"2026-08-06T20:14:46.821080+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"ICU Medical Q2 GAAP EPS $0.76, adjusted EPS $2.37; organic revenue up 6%","bullets":["GAAP revenue $551.7M (+1% YoY); non-GAAP organic revenue +6% excluding IV Solutions divestiture and FX.","GAAP net income $19.1M ($0.76 diluted EPS) vs $35.3M ($1.43) in Q2 2025.","Adjusted diluted EPS $2.37 vs $2.10; adjusted EBITDA $110.0M vs $100.3M.","GAAP gross margin improved to 43% from 38% YoY.","FY2026 guidance updated; specific numbers not available in provided excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-26-000040","json":"https://secwatch.observer/filing/0000883984-26-000040.json","markdown":"https://secwatch.observer/filing/0000883984-26-000040.md","text":"https://secwatch.observer/filing/0000883984-26-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000040/0000883984-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000040/icui-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:14:46.821080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}